| Title |
Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment
|
|---|---|
| Published in |
Clinical Ophthalmology, January 2013
|
| DOI | 10.2147/opth.s37938 |
| Pubmed ID | |
| Authors |
Samuel K Houston, Nisha V Shah, Christina Decatur, Marcela Lonngi, William Feuer, Arnold M Markoe, Timothy G Murray |
| Abstract |
The purpose of this study was to evaluate intravitreal bevacizumab as an adjuvant treatment to plaque brachytherapy in the treatment of choroidal melanoma. |
Mendeley readers
The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 13 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 5 | 38% |
| Lecturer > Senior Lecturer | 1 | 8% |
| Professor | 1 | 8% |
| Student > Ph. D. Student | 1 | 8% |
| Student > Master | 1 | 8% |
| Other | 1 | 8% |
| Unknown | 3 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 62% |
| Physics and Astronomy | 1 | 8% |
| Nursing and Health Professions | 1 | 8% |
| Unknown | 3 | 23% |